Form 4 Tracker
Travere Therapeutics, Inc.
TVTX

60 insider filings · Latest: Sep 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 6, 2025Feb 6 9:21 PMROY D BAYNES
Proposed Sale
10,000$22.00$220.0K—

View →

Feb 4, 2025Feb 4 9:11 PMJULA INRIG
Proposed Sale
1,066$20.11$21.4K—

View →

Feb 3, 2025Feb 4 1:47 AMPeter Heerma
Proposed Sale
5,166$20.12$103.9K—

View →

Feb 3, 2025Feb 4 1:46 AMChristopher Cline
Proposed Sale
5,192$20.12$104.5K—

View →

Feb 3, 2025Feb 4 1:41 AMSandra Calvin
Proposed Sale
3,348$20.12$67.4K—

View →

Feb 3, 2025Feb 4 1:40 AMJula Inrig
Proposed Sale
4,207$20.12$84.6K—

View →

Feb 3, 2025Feb 3 5:26 PMREED ELIZABETH E
Proposed Sale
8,951$19.78$177.1K—

View →

Feb 3, 2025Feb 3 4:22 PMDube Eric M
Proposed Sale
50,691$19.78$1.0M—

View →

Feb 3, 2025Feb 3 4:11 PMROTE WILLIAM E.
Proposed Sale
8,951$19.78$177.1K—

View →

Jan 23, 2025Jan 23 9:14 PMROY D BAYNES
Proposed Sale
16,000$20.00$320.0K—

View →

Jan 22, 2025Jan 22 3:34 PMDube Eric M
Proposed Sale
10,736$19.46$208.9K—

View →

Jan 22, 2025Jan 22 3:18 PMREED ELIZABETH E
Proposed Sale
2,437$19.46$47.4K—

View →

Jan 22, 2025Jan 22 2:36 PMROTE WILLIAM E.
Proposed Sale
2,437$19.46$47.4K—

View →

Dec 26, 2024Dec 26 9:13 PMSANDRA CALVIN
Proposed Sale
15,000$17.22$258.3K—

View →

Nov 25, 2024Nov 25 10:59 PMCalvin Sandra
Proposed Sale
12,090$18.30$221.3K—

View →

Oct 4, 2024Oct 4 8:21 PMGARY A LYONS
Proposed Sale
40,000$13.65$546.0K—

View →

Sep 30, 2024Sep 30 8:22 PMJEFFREY MECKLER
Proposed Sale
40,000$14.06$562.3K—

View →

Sep 11, 2024Sep 11 10:29 PMCalvin Sandra
Proposed Sale
15,000$14.80$222.0K—

View →

Sep 9, 2024Sep 9 2:54 PMREED ELIZABETH E
Proposed Sale
4,387$11.52$50.5K—

View →

Sep 9, 2024Sep 9 2:35 PMROTE WILLIAM E.
Proposed Sale
4,387$11.52$50.5K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 16, 2026Sep 18 1:35 AMWilliam E. RoteChief Research Officer
Option Exercise
112,850$26.880(D)

View →

Sep 15, 2026Sep 18 1:35 AMWilliam E. RoteChief Research Officer
Option Exercise
78,650$25.25350(D)

View →

Sep 17, 2026Sep 18 1:35 AMPeter HeermaEVP, CHIEF COMMERCIAL OFFICER
Option Exercise
8,282$22.4044,837(D)

View →

Sep 16, 2026Sep 18 1:35 AMPeter HeermaEVP, CHIEF COMMERCIAL OFFICER
Option Exercise
172,717$26.88500(D)

View →

Sep 15, 2026Sep 18 1:35 AMPeter HeermaEVP, CHIEF COMMERCIAL OFFICER
Option Exercise
77,190$26.8828,474(D)

View →

Sep 15, 2026Sep 18 1:33 AMJula InrigEVP, Head of R&D & CMO
Option Exercise
32,395$8.9343,605(D)

View →

Sep 15, 2026Sep 18 1:32 AMElizabeth E ReedChief Legal Officer and GC
Option Exercise
37,500$15.460(D)

View →

Sep 17, 2026Sep 18 1:31 AMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
108,493$23.340(D)

View →

Sep 16, 2026Sep 18 1:31 AMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
195,841$23.34108,493(D)

View →

Sep 15, 2026Sep 18 1:31 AMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
95,666$23.34304,334(D)

View →

Sep 15, 2026Sep 18 1:30 AMChristopher R. ClineCHIEF FINANCIAL OFFICER
Option Exercise
20,000$17.440(D)

View →

Sep 15, 2026Sep 18 1:29 AMSandra CalvinSVP, CHIEF ACCOUNTING OFFICER
Option Exercise
5,375$27.5017,875(D)

View →

Sep 10, 2026Sep 11 8:05 PMMeckler Jeffrey ADirector
Option Exercise
20,000$26.520(D)

View →

Aug 18, 2026Aug 19 8:05 PMLYONS GARY ADirector
Option Exercise
5,000$17.440(D)

View →

Aug 17, 2026Aug 19 8:05 PMLYONS GARY ADirector
Option Exercise
5,000$17.445,000(D)

View →

Jun 12, 2026Jun 16 8:46 PMTimothy CoughlinDirector
Option Exercise
10,000$26.520(D)

View →

Jun 12, 2026Jun 16 8:42 PMRoy D. BaynesDirector
Option Exercise
4,500$21.380(D)

View →

May 19, 2026May 21 9:00 PMBrinkley Ruth WilliamsDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMRon SquarerDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMSandra PooleDirector
Grant/Award
12,000$42.2612,000(D)

View →

Page 1 of 4

Next →